amylin, in its natural form, is sticky—it clumps on needles and forms little rocks in the pancreas. researchers first had to create a synthetic version that they could work with more easily and reliably. the inventors at amylin pharmaceuticals—laura gaeta, howard jones, and elisabeth albrecht—altered amino acids in the molecule and created a new drug named pramlintide.